TMC Life Sciences Berhad (KLSE:TMCLIFE)

Market Cap	818.68M
Revenue (ttm)	345.63M
Net Income (ttm)	3.61M
Shares Out	1.74B
EPS (ttm)	0.00
PE Ratio	227.05
Forward PE	n/a
Dividend	0.00 (0.40%)
Ex-Dividend Date	Dec 8, 2025

Volume	276,100
Average Volume	172,270
Open	0.4700
Previous Close	0.4700
Day's Range	0.4650 - 0.4800
52-Week Range	0.3650 - 0.5500
Beta	0.39
RSI	72.52
Earnings Date	Nov 17, 2025

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1994
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: TMCLIFE

Financial Performance

In 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.